COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine - We Should be Prepared
Open Access
- 1 April 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Disaster Medicine and Public Health Preparedness
- Vol. 16 (2), 718-725
- https://doi.org/10.1017/dmp.2020.349
Abstract
Between December 31, 2019, and August 30, 2020 (date of this article), the novel coronavirus and its corresponding infection, coronavirus disease (COVID-19), increased to more than 25 million cases, and 843 158 deaths have been registered. Countries around the world have been affected, albeit in different levels and intensities. Despite implementations of preventive public health measures, most countries are seriously preparing for 1 or more waves. The threat of this surge is likely to persist until herd immunity is acquired either by natural infection or through vaccination. However, given the time frame needed for herd immunity to occur and the low probability that a vaccine will be available on a global scale by the coming fall and winter seasons, contingency preparedness plans should be established and put in place for the coming days or months. These plans should help mitigate new peaks of the pandemic while relaxing the social isolation rules, patient, public health, and hospital levels. In this article, we discuss recommendations that practicing physicians and public health agencies should provide to individuals, especially those at risk of infection, to take and implement pre-emptive measures in anticipation of the potential next peak of the pandemic.Keywords
This publication has 60 references indexed in Scilit:
- Zinc for the common coldCochrane Database of Systematic Reviews, 2015
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in AdultsNew England Journal of Medicine, 2015
- Achieving “Zero” CLABSI and VAP after Sequential Implementation of Central Line Bundle and Ventilator BundleInfection Control & Hospital Epidemiology, 2014
- Annual public health and economic benefits of seasonal influenza vaccination: a European estimateBMC Public Health, 2014
- Vitamin C for preventing and treating pneumoniaEmergencias, 2013
- Vitamin C for preventing and treating the common coldCochrane Database of Systematic Reviews, 2013
- Factors Predicting Mortality in Invasive Pneumococcal Disease in Adults in AlbertaMedicine, 2011
- Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common coldInternational Journal of General Medicine, 2011
- Fatalities Associated with the 2009 H1N1 Influenza A Virus in New York CityClinical Infectious Diseases, 2010
- Bacterial Pathogens and Death during the 1918 Influenza PandemicNew England Journal of Medicine, 2009